• Medical - Instruments & Supplies
  • Healthcare
Teleflex Incorporated logo
Teleflex Incorporated
TFX · US · NYSE
222.59
USD
+0.8
(0.36%)
Company Overview

550 E SWEDESFORD RD,WAYNE PA 19087,610-225-6800

CEO

Mr. Liam J. Kelly

Employess

14500

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Website

https://www.teleflex.com

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Next Earnings Date

Oct. 31, 2024

Ex Dividends date

Jun. 14, 2024

Dividend Date

May 14, 2024

YTD Performance

-11.12%

Fiscal Year End

12-31

IPO Date

1980-03-17

Growth Rates
(avg. rate of change) 10 years 5 years 3 years 1 year
Sales/Revenue 5.78% 3.97% 5.44% 6.57%
EPS 7.52% 11.54% 1.68% -2.07%
Equity 8.78% 11.82% 10.00% 10.42%
Cash -6.40% -9.00% -15.99% -23.69%
Return On Capital (ROIC) 7.98% 8.28% 7.67% 6.55%
Debt
year (millions) 2023 2022 2021 2020 2019
Short Term Debt 87.5 87.5 110 100 50
Long Term Debt 1,840 1,740 1,860 2,460 1,960
LT Finance Leases 111 120 116 86.1 101
Shares Outstanding 47 46.9 46.8 46.5 46.2
Market Cap 11,700 11,700 15,400 19,100 17,400
Price
Business Segments (Beta)
Geographical Segments (Beta)
News
Teleflex Announces Second Quarter 2024 Earnings Conference Call Information
2 months

WAYNE, Pa., July 18, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its second quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, August 1, 2024.

globenewswire.com
What Makes Teleflex (TFX) a New Buy Stock
2 months

Teleflex (TFX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

zacks.com
TFX vs. SONVY: Which Stock Is the Better Value Option?
2 months

Investors with an interest in Medical - Instruments stocks have likely encountered both Teleflex (TFX) and SONOVA HOLDING (SONVY). But which of these two stocks presents investors with the better value opportunity right now?

zacks.com
This Medical Devices Stock Has Several Catalysts, Says Bullish Analyst
3 months

Teleflex Inc TFX benefited in the first quarter from the surge in the interventional segment and other tailwinds.

benzinga.com
Is it Wise to Hold Teleflex (TFX) Stock in Your Portfolio Now?
3 months

Teleflex (TFX) holds strong momentum in the Interventional arm and a favorable solvency. Yet, macroeconomic impacts and competitive environment trigger concerns.

zacks.com
US FDA classifies recall of Teleflex's inflatable devices as 'most serious'
3 months

The U.S. Food and Drug Administration classified a recall of Teleflex's inflatable devices that increase blood supply to the heart muscle as "most serious".

reuters.com
Teleflex's (TFX) Urolift Drives Market Share, Macro Woes Stay
4 months

The commercialization of Teleflex's (TFX) UroLift in Japan has been a significant step toward making this therapy more broadly available to men suffering from BPH.

zacks.com
Here's Why Teleflex (TFX) is a Strong Value Stock
4 months

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

zacks.com
Why Teleflex (TFX) is a Top Momentum Stock for the Long-Term
4 months

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

zacks.com
Teleflex (TFX) is a Top-Ranked Growth Stock: Should You Buy?
4 months

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

zacks.com
Why Teleflex (TFX) is a Top Value Stock for the Long-Term
4 months

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

zacks.com
Teleflex (TFX) Expands Vascular Access Portfolio With New Launch
4 months

Teleflex (TFX) debuts the new Arrow EZ-IO Intraosseous Access Procedure Tray.

zacks.com